Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
27 Mar 2015 ESMO Press Release: Clinical Trial Design in the Era of Targeted Therapies
25 Mar 2015 New Insights Into Survival Outcomes of Asian Americans Diagnosed with Cancer Epidemiology/Etiology/Cancer Prevention
25 Mar 2015 EMA's Pharmacovigilance Risk Assessment Committee Recommends Further Measures to Minimise Risk of Osteonecrosis of the Jaw with Bisphosphonate Medicine Palliative and supportive care
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy
10 Mar 2015 FDA Approves First Biosimilar Product in the USA Palliative and supportive care
09 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Pegfilgrastim (Ristempa) Palliative and supportive care
06 Mar 2015 FDA Expands Approved Use of Nivolumab to Squamous NSCLC Lung and other thoracic tumours - Immuno-oncology
05 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
03 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 Mar 2015 Adjuvant VEGF Inhibitors, Sorafenib or Sunitinib, do not Improve Outcomes in Resected Locally-Advanced Renal Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
25 Feb 2015 FDA Approves Panobinostat for Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
23 Feb 2015 FDA Permits Marketing of First Direct-to-Consumer Genetic Carrier Test for Bloom Syndrome Epidemiology/Etiology/Cancer Prevention
18 Feb 2015 Genomic Profiling of Cancer of Unknown Primary Site Translational research - Carcinoma of unknown primary site
17 Feb 2015 FDA Approves Lenvatinib for Differentiated Thyroid Cancer Refractory to Iodine-131 Endocrine cancers - Anticancer agents & Biologic therapy